BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19233433)

  • 1. Oncological followup after radical cystectomy for bladder cancer-is there any benefit?
    Volkmer BG; Kuefer R; Bartsch GC; Gust K; Hautmann RE
    J Urol; 2009 Apr; 181(4):1587-93; discussion 1593. PubMed ID: 19233433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival.
    Boorjian SA; Tollefson MK; Cheville JC; Costello BA; Thapa P; Frank I
    J Urol; 2011 Nov; 186(5):1796-802. PubMed ID: 21944088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience.
    Hemal AK; Kolla SB
    J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.
    Akkad T; Gozzi C; Deibl M; Müller T; Pelzer AE; Pinggera GM; Bartsch G; Steiner H
    J Urol; 2006 Apr; 175(4):1268-71; discussion 1271. PubMed ID: 16515977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.
    Mitra AP; Quinn DI; Dorff TB; Skinner EC; Schuckman AK; Miranda G; Gill IS; Daneshmand S
    BJU Int; 2012 Mar; 109(6):846-54. PubMed ID: 21812902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.
    Lin DW; Herr HW; Dalbagni G
    J Urol; 2003 Mar; 169(3):961-3. PubMed ID: 12576822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial cystectomy during radical surgery for nonurological malignancy.
    Weinstein RP; Grob BM; Pachter EM; Soloway S; Fair WR
    J Urol; 2001 Jul; 166(1):79-81. PubMed ID: 11435828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years.
    Haber GP; Gill IS
    BJU Int; 2007 Jul; 100(1):137-42. PubMed ID: 17552961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seminal sparing cystectomy and ileocapsuloplasty: long-term followup results.
    Muto G; Bardari F; D'Urso L; Giona C
    J Urol; 2004 Jul; 172(1):76-80. PubMed ID: 15201741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper urinary tract recurrence following radical cystectomy for bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2007 Jun; 14(6):496-9. PubMed ID: 17593092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological outcome after radical cystectomy and orthotopic bladder substitution in women.
    Ali-El-Dein B
    Eur J Surg Oncol; 2009 Mar; 35(3):320-5. PubMed ID: 18434072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era.
    Hautmann RE; Gschwend JE; de Petriconi RC; Kron M; Volkmer BG
    J Urol; 2006 Aug; 176(2):486-92; discussion 491-2. PubMed ID: 16813874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder.
    Westney OL; Pisters LL; Pettaway CA; Tu SM; Pollack A; Dinney CP
    J Urol; 1998 Mar; 159(3):792-5. PubMed ID: 9474150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup.
    Schoenberg MP; Walsh PC; Breazeale DR; Marshall FF; Mostwin JL; Brendler CB
    J Urol; 1996 Feb; 155(2):490-4. PubMed ID: 8558643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
    Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
    J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.